Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index
July 29, 2024 08:30 ET
|
Carmell Corporation
Carmell Corp (Nasdaq: CTCX) announced the appointment of Kendra Bracken-Ferguson as CEO effective July 30, 2024 with Rajiv Shukla continuing as Chairman.
Carmell Announces Successful Closing of $3.0 Million Private Placement
April 11, 2024 16:30 ET
|
Carmell Corporation
PITTSBURGH, April 11, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today...
Carmell Announces $3.0 Million Private Placement
April 04, 2024 08:30 ET
|
Carmell Corporation
PITTSBURGH, April 04, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today...
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction
March 27, 2024 09:15 ET
|
Carmell Corporation
PITTSBURGH, March 27, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today...
Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary
March 20, 2024 16:39 ET
|
Carmell Corporation
Carmell today announced the execution of a definitive agreement to sell its wholly owned subsidiary Axolotl Biologix
Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field
March 18, 2024 15:16 ET
|
Carmell Corporation
Carmell to host an Investor Webinar titled “Unveiling the Secretome: On the Eve of Product Launch”